Miguel Muzzio

2.2k total citations · 1 hit paper
31 papers, 1.2k citations indexed

About

Miguel Muzzio is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Miguel Muzzio has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Miguel Muzzio's work include Estrogen and related hormone effects (8 papers), Breast Cancer Treatment Studies (7 papers) and Cancer therapeutics and mechanisms (5 papers). Miguel Muzzio is often cited by papers focused on Estrogen and related hormone effects (8 papers), Breast Cancer Treatment Studies (7 papers) and Cancer therapeutics and mechanisms (5 papers). Miguel Muzzio collaborates with scholars based in United States, Philippines and Germany. Miguel Muzzio's co-authors include David L. McCormick, Izet M. Kapetanović, Zhihua Huang, Thomas N. Thompson, William D. Johnson, James A. Crowell, Robert L. Morrissey, Amy Usborne, Xinjian Peng and Fatouma Alimirah and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Miguel Muzzio

31 papers receiving 1.1k citations

Hit Papers

Pharmacokinetics, oral bioavailability, and metabolic pro... 2010 2026 2015 2020 2010 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miguel Muzzio United States 14 477 345 171 159 114 31 1.2k
Jung Ho Back United States 10 619 1.3× 516 1.5× 168 1.0× 135 0.8× 95 0.8× 10 1.2k
Anand Krishnan V. Iyer United States 25 824 1.7× 100 0.3× 207 1.2× 117 0.7× 257 2.3× 50 1.5k
Roberta Giordo Italy 25 697 1.5× 124 0.4× 86 0.5× 110 0.7× 130 1.1× 56 1.8k
Allan Lançon France 14 638 1.3× 603 1.7× 132 0.8× 161 1.0× 127 1.1× 18 1.3k
Valeria Cucciolla Italy 18 643 1.3× 294 0.9× 254 1.5× 121 0.8× 141 1.2× 21 1.4k
Eduardo Cremonese Filippi‐Chiela Brazil 20 920 1.9× 162 0.5× 237 1.4× 172 1.1× 225 2.0× 59 1.8k
Subhendu Mukherjee United States 23 701 1.5× 360 1.0× 123 0.7× 255 1.6× 106 0.9× 56 1.7k
Jeong‐Hyeon Ko South Korea 22 1.1k 2.4× 271 0.8× 475 2.8× 90 0.6× 352 3.1× 38 2.1k
Aranka Brockmueller Germany 19 530 1.1× 110 0.3× 163 1.0× 52 0.3× 206 1.8× 33 1.1k

Countries citing papers authored by Miguel Muzzio

Since Specialization
Citations

This map shows the geographic impact of Miguel Muzzio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel Muzzio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel Muzzio more than expected).

Fields of papers citing papers by Miguel Muzzio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miguel Muzzio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel Muzzio. The network helps show where Miguel Muzzio may publish in the future.

Co-authorship network of co-authors of Miguel Muzzio

This figure shows the co-authorship network connecting the top 25 collaborators of Miguel Muzzio. A scholar is included among the top collaborators of Miguel Muzzio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miguel Muzzio. Miguel Muzzio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Oukseub, Minhua Wang, Omid Hosseini, et al.. (2023). Z-Endoxifen prevents aggressive mammary cancers in mice by inhibiting cell proliferation and creating a tumor suppressive microenvironment.. Biomedicine & Pharmacotherapy. 162. 114607–114607. 1 indexed citations
2.
Patel, Anisha B., J. Jack Lee, Diane D. Liu, et al.. (2022). Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer. Cancer Prevention Research. 16(1). 47–55. 4 indexed citations
3.
Zhang, Daniel Y., Crismita Dmello, Li Chen, et al.. (2019). Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations. Clinical Cancer Research. 26(2). 477–486. 124 indexed citations
4.
Lee, Oukseub, Megan Sullivan, Yanfei Xu, et al.. (2019). Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate. Clinical Cancer Research. 26(1). 25–34. 23 indexed citations
5.
Lee, Oukseub, Richard E. Heinz, David Ivancic, et al.. (2018). Breast Hormone Concentrations in Random Fine-Needle Aspirates of Healthy Women Associate with Cytological Atypia and Gene Methylation. Cancer Prevention Research. 11(9). 557–568. 4 indexed citations
6.
Činátl, Jindřich, David A. Boltz, Xiang Peng, et al.. (2018). Antiviral effect of a derivative of isonicotinic acid enisamium iodide (FAV00A) against influenza virus. Acta Virologica. 62(2). 191–195. 12 indexed citations
7.
Lee, Oukseub, David Ivancic, Irene Helenowski, et al.. (2015). Local transdermal therapy to the breast for breast cancer prevention and DCIS therapy: preclinical and clinical evaluation. Cancer Chemotherapy and Pharmacology. 76(6). 1235–1246. 33 indexed citations
8.
Muzzio, Miguel, Julianne L. Holleran, Robert A. Parise, et al.. (2015). Plasma pharmacokinetics of the indenoisoquinoline topoisomerase I inhibitor, NSC 743400, in rats and dogs. Cancer Chemotherapy and Pharmacology. 75(5). 1015–1023. 2 indexed citations
9.
Chatterton, Robert T., Miguel Muzzio, Richard E. Heinz, Peter H. Gann, & Seema A. Khan. (2014). Methodological considerations in estrogen assays of breast fluid and breast tissue. Steroids. 99(Pt A). 103–107. 6 indexed citations
10.
Mehta, Rajeshwari R., Fatouma Alimirah, Rutulkumar Patel, et al.. (2013). Deguelin Action Involves c-Met and EGFR Signaling Pathways in Triple Negative Breast Cancer Cells. PLoS ONE. 8(6). e65113–e65113. 61 indexed citations
11.
Mehta, Rajeshwari R., D. Kalra, Rutulkumar Patel, et al.. (2013). Efficacy and mechanism of action of Deguelin in suppressing metastasis of 4T1 cells. Clinical & Experimental Metastasis. 30(7). 855–866. 24 indexed citations
12.
Muzzio, Miguel, et al.. (2012). Toxicologic evaluation of tungsten: 28-day inhalation study of tungsten blue oxide in rats. Inhalation Toxicology. 24(14). 985–994. 13 indexed citations
13.
Kapetanović, Izet M., Miguel Muzzio, David L. McCormick, et al.. (2012). Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats. Cancer Chemotherapy and Pharmacology. 69(5). 1301–1306. 5 indexed citations
14.
Johnson, William D., Robert L. Morrissey, Amy Usborne, et al.. (2011). Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity. Food and Chemical Toxicology. 49(12). 3319–3327. 93 indexed citations
15.
Muzzio, Miguel, Zhihua Huang, William D. Johnson, David L. McCormick, & Izet M. Kapetanović. (2011). Determination and stability of CP-31398 in plasma from experimental animals by LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 56(4). 809–814. 4 indexed citations
16.
Johnson, William D., Miguel Muzzio, Carol J. Detrisac, et al.. (2011). Subchronic oral toxicity and metabolite profiling of the p53 stabilizing agent, CP-31398, in rats and dogs. Toxicology. 289(2-3). 141–150. 12 indexed citations
17.
Muzzio, Miguel, et al.. (2011). Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC–MS/MS and their pharmacokinetics in dogs. Journal of Pharmaceutical and Biomedical Analysis. 59. 201–208. 65 indexed citations
18.
Jia, Lee, Gregory S. Gorman, Lori Coward, et al.. (2010). Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination. Cancer Chemotherapy and Pharmacology. 68(2). 513–524. 56 indexed citations
19.
Kapetanović, Izet M., Miguel Muzzio, James A. Crowell, et al.. (2009). Pharmacokinetics and enhanced bioavailability of candidate cancer preventative agent, SR13668 in dogs and monkeys. Cancer Chemotherapy and Pharmacology. 65(6). 1109–1116. 14 indexed citations
20.
Gaworski, Charles L., T.J. Meisgen, F.J. Tewes, et al.. (2009). Effect of filtration by activated charcoal on the toxicological activity of cigarette mainstream smoke from experimental cigarettes. Inhalation Toxicology. 21(8). 688–704. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026